Synthesis of Substances for Pharmacological Testing

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

HEADQUATERS

Contract Value

Not provided

Codes & Classification
Solicitation Number

D-26-DO-0018

NAICS

325199 - All Other Basic Organic Chemical Manufacturing

Classification Code

6810

Additional Details
Set Aside

None

Place of Performance

Dulles, Virginia, UNITED STATES

SourceSAM
Documents1
The Drug Enforcement Administration (DEA), operating under the Department of Justice, has issued a combined synopsis/solicitation for the synthesis of substances intended for pharmacological testing. This procurement activity is designed to support the DEA’s ongoing research and enforcement initiatives by acquiring specialized organic chemical compounds for laboratory evaluation and analysis. The scope of work encompasses the synthesis of various basic organic chemicals, as classified under NAICS Code 325199 (All Other Basic Organic Chemical Manufacturing), with a specific focus on substances required for pharmacological testing. Contractors are expected to possess the technical expertise and facilities necessary to manufacture these compounds in accordance with stringent quality and safety standards. The deliverables will likely include the provision of synthesized substances, documentation of synthesis processes, and assurance of purity and compliance suitable for scientific testing. The place of performance for this contract is Dulles, Virginia, indicating that either the delivery or the primary operations will be centered in this location. The procurement is managed by the DEA Headquarters Office, a federal entity, with Ms. Angel Barkley serving as the primary point of contact ([email protected]). Interested parties should note the active status of the notice and the relatively short response window, with submissions due by September 25, 2026. This opportunity is classified under Product Service Code 6810, which pertains to chemicals, further emphasizing the technical nature of the requirement. The solicitation is accessible via SAM.gov, where additional attachments may provide further details regarding specifications and submission requirements. Contractors evaluating this opportunity should ensure alignment with the DEA’s requirements for chemical synthesis, regulatory compliance, and secure handling of substances. The procurement type is a combined synopsis/solicitation, streamlining the process for both announcement and proposal submission. No set-aside requirements or special considerations are specified in the notice, but adherence to federal contracting standards and DEA protocols is implicit. Overall, this contract represents a critical support function for the DEA’s scientific and enforcement missions, requiring reliable, high-quality synthesis of organic compounds for pharmacological testing. Contractors with proven capabilities in chemical manufacturing and a strong compliance record are encouraged to review the solicitation and consider participation.